|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:acquiredBy
|
gptkb:Elder_Pharmaceuticals_(India_operations)
gptkb:Unichem_Laboratories_(India_branded_business)
|
|
gptkbp:CEO
|
gptkb:Samarjeet_Singh
|
|
gptkbp:chairman
|
gptkb:Sudhir_Mehta
|
|
gptkbp:focusArea
|
gptkb:Pediatrics
gptkb:Central_nervous_system
Oncology
Nutraceuticals
Dermatology
Nephrology
Gynecology
Pain management
Cardiovascular
Diabetology
Gastrointestinal
Anti-infective
|
|
gptkbp:foundedIn
|
1959
|
|
gptkbp:founder
|
gptkb:U._N._Mehta
|
|
gptkbp:headquartersLocation
|
gptkb:Ahmedabad,_Gujarat,_India
|
|
gptkbp:industry
|
Pharmaceuticals
|
|
gptkbp:ISIN
|
INE685A01028
|
|
gptkbp:keyPerson
|
gptkb:Amit_Choksey
gptkb:Amitabh_Chaturvedi
gptkb:Jinal_Mehta
gptkb:Sanjay_Gupta
|
|
gptkbp:listedOn
|
gptkb:Bombay_Stock_Exchange
gptkb:National_Stock_Exchange_of_India
|
|
gptkbp:manufacturingFacilities
|
gptkb:Brazil
gptkb:Germany
gptkb:India
gptkb:United_States
|
|
gptkbp:numberOfEmployees
|
13,000+
|
|
gptkbp:operatesIn
|
gptkb:Brazil
gptkb:Germany
gptkb:India
gptkb:Philippines
gptkb:Russia
gptkb:United_States
Other international markets
|
|
gptkbp:parentCompany
|
gptkb:Torrent_Group
|
|
gptkbp:products
|
Active pharmaceutical ingredients
Generic drugs
Formulations
|
|
gptkbp:R&DFacilities
|
gptkb:Dahej,_Gujarat,_India
gptkb:Pithampur,_Madhya_Pradesh,_India
gptkb:Baddi,_Himachal_Pradesh,_India
gptkb:Sikkim,_India
gptkb:Gujarat,_India
|
|
gptkbp:revenue
|
₹8,508 crore (FY 2022-23)
|
|
gptkbp:stockExchange
|
gptkb:NSE
BSE
|
|
gptkbp:stockSymbol
|
gptkb:TORNTPHARM
|
|
gptkbp:subsidiary
|
gptkb:Heumann_Pharma
|
|
gptkbp:website
|
https://www.torrentpharma.com/
|
|
gptkbp:bfsParent
|
gptkb:Bharuch
|
|
gptkbp:bfsLayer
|
6
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Torrent Pharmaceuticals
|